These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 26882953

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Transcription Factor MafB Promotes Hepatocellular Carcinoma Cell Proliferation through Up-Regulation of Cyclin D1.
    Yu H, Jiang HL, Xu D, Jin JZ, Zhao ZM, Ma YD, Liang J.
    Cell Physiol Biochem; 2016; 39(2):700-8. PubMed ID: 27448450
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. MicroRNA-155 promotes tumor growth of human hepatocellular carcinoma by targeting ARID2.
    Zhang L, Wang W, Li X, He S, Yao J, Wang X, Zhang D, Sun X.
    Int J Oncol; 2016 Jun; 48(6):2425-34. PubMed ID: 27035278
    [Abstract] [Full Text] [Related]

  • 6. MicroRNA-301b-3p contributes to tumour growth of human hepatocellular carcinoma by repressing vestigial like family member 4.
    Guo Y, Yao B, Zhu Q, Xiao Z, Hu L, Liu X, Li L, Wang J, Xu Q, Yang L, Huang D.
    J Cell Mol Med; 2019 Aug; 23(8):5037-5047. PubMed ID: 31207037
    [Abstract] [Full Text] [Related]

  • 7. MicroRNA-92a contributes to tumor growth of human hepatocellular carcinoma by targeting FBXW7.
    Yang W, Dou C, Wang Y, Jia Y, Li C, Zheng X, Tu K.
    Oncol Rep; 2015 Nov; 34(5):2576-84. PubMed ID: 26323375
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Zinc finger protein ZBTB20 is an independent prognostic marker and promotes tumor growth of human hepatocellular carcinoma by repressing FoxO1.
    Kan H, Huang Y, Li X, Liu D, Chen J, Shu M.
    Oncotarget; 2016 Mar 22; 7(12):14336-49. PubMed ID: 26893361
    [Abstract] [Full Text] [Related]

  • 11. The long non-coding RNA PTTG3P promotes cell growth and metastasis via up-regulating PTTG1 and activating PI3K/AKT signaling in hepatocellular carcinoma.
    Huang JL, Cao SW, Ou QS, Yang B, Zheng SH, Tang J, Chen J, Hu YW, Zheng L, Wang Q.
    Mol Cancer; 2018 May 26; 17(1):93. PubMed ID: 29803224
    [Abstract] [Full Text] [Related]

  • 12. Upregulation of DARS2 by HBV promotes hepatocarcinogenesis through the miR-30e-5p/MAPK/NFAT5 pathway.
    Qin X, Li C, Guo T, Chen J, Wang HT, Wang YT, Xiao YS, Li J, Liu P, Liu ZS, Liu QY.
    J Exp Clin Cancer Res; 2017 Oct 19; 36(1):148. PubMed ID: 29052520
    [Abstract] [Full Text] [Related]

  • 13. Overexpression of SYF2 correlates with enhanced cell growth and poor prognosis in human hepatocellular carcinoma.
    Zhang S, Shi W, Chen Y, Xu Z, Zhu J, Zhang T, Huang W, Ni R, Lu C, Zhang X.
    Mol Cell Biochem; 2015 Dec 19; 410(1-2):1-9. PubMed ID: 26260052
    [Abstract] [Full Text] [Related]

  • 14. Hepatitis B virus promotes proliferation and metastasis in male Chinese hepatocellular carcinoma patients through the LEF-1/miR-371a-5p/SRCIN1/pleiotrophin/Slug pathway.
    Bai PS, Hou P, Kong Y.
    Exp Cell Res; 2018 Sep 01; 370(1):174-188. PubMed ID: 29928866
    [Abstract] [Full Text] [Related]

  • 15. Overexpression of p42.3 promotes cell growth and tumorigenicity in hepatocellular carcinoma.
    Sun W, Dong WW, Mao LL, Li WM, Cui JT, Xing R, Lu YY.
    World J Gastroenterol; 2013 May 21; 19(19):2913-20. PubMed ID: 23704824
    [Abstract] [Full Text] [Related]

  • 16. LncRNA H19 promotes the development of hepatitis B related hepatocellular carcinoma through regulating microRNA-22 via EMT pathway.
    Li L, Han T, Liu K, Lei CG, Wang ZC, Shi GJ.
    Eur Rev Med Pharmacol Sci; 2019 Jun 21; 23(12):5392-5401. PubMed ID: 31298392
    [Abstract] [Full Text] [Related]

  • 17. Overexpression of Rab5a promotes hepatocellular carcinoma cell proliferation and invasion via FAK signaling pathway.
    Geng D, Zhao W, Feng Y, Liu J.
    Tumour Biol; 2016 Mar 21; 37(3):3341-7. PubMed ID: 26443539
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. TPX2 silencing exerts anti‑tumor effects on hepatocellular carcinoma by regulating the PI3K/AKT signaling pathway.
    Huang DH, Jian J, Li S, Zhang Y, Liu LZ.
    Int J Mol Med; 2019 Dec 21; 44(6):2113-2122. PubMed ID: 31638175
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.